Chinese yellow wine and red wine inhibit matrix metalloproteinase-2 and improve atherosclerotic plaque in LDL receptor knockout mice

Cardiovascular Therapeutics

Volumn 28, Issue 3, 2010, Pages 161-168

  Guo, Hangyuan ^a   Liu, Longbin ^a   Shi, Yafei ^b   Sun, Aijing ^a   Xu, Fukang ^a   Chi, Jufang ^a   Huang, Dilai ^a  

^a SHAOXING UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Homocysteine; LDL Receptor knockout mice; Matrix metalloproteinase; Yellow wine rice wine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; GELATINASE A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID; MATRIX METALLOPROTEINASE INHIBITOR; MMP2 PROTEIN, MOUSE; PROTEINASE INHIBITOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; AORTA SINUS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SYNTHESIS; HYPERHOMOCYSTEINEMIA; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; RED WINE; TRIACYLGLYCEROL BLOOD LEVEL; WINE; YELLOW WINE; ANIMAL; AORTIC DISEASES; BLOOD; C57BL MOUSE; CHINA; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENETICS; MALE; METABOLISM; MOUSE; PATHOLOGY;

ALANINE TRANSAMINASE; ANIMALS; AORTIC DISEASES; ASPARTATE AMINOTRANSFERASES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHINA; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HOMOCYSTEINE; LIPIDS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE INHIBITORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEASE INHIBITORS; RECEPTORS, LDL; WINE;

EID: 77952133678     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2009.00132.x     Document Type: Article

References (43)

1. Gronbaek M, Deis A, Sorensen TI, Becker U, Schnohr P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 1995 310 : 1165 1169.
2. Kloner RA, Rezkalla SH. To drink or not to drink? That is the question. Circulation 2007 116 : 1306 1317.
3. Vinson JA, Teufel K, Wu N. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 2001 156 : 67 72.
4. Hayek T, Fuhrman B, Vaya J, et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol 1997 17 : 2744 2752.
5. da Luz PL, Serrano Júnior CV, Chacra AP, et al. The effect of red wine on experimental atherosclerosis: Lipid-independent protection. Exp Mol Pathol 1999 65 : 150 159.
6. Li Z, Li L, Zielke HR, Cheng L, Xiao R, Crow MT, Stetler-Stevenson WG. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 1996 148 : 121 128.
7. Pasterkamp G, Schoneveld AH, Hijnen DJ, de Kleijn DP, Teepen H, Van Der Wal AC, Borst C. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 2000 150 : 245 253.
8. Oak MH, El Bedoui J, Anglard P, Schini-Kerth VB. Red wine polyphenolic compounds strongly inhibit pro-matrix metallo-proteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle ells. Circulation 2004 110 : 1861 1867.
9. Chen C, Yin ZJ, Xu S. The history and nutrition value of yellow wine. Liquor Making 2002 29 : 55 56.
10. Que F, Mao LC, Zhu CG. Antioxidant properties of Chinese yellow wine, its concentrate and volatiles. LWT-Food Sci Technol 2006 39 : 111 117.
11. Hu PX. Development trend and current technology situations of Chinese rice wine. China Brewing 2008 180 : 4 6.
12. Wang JG. The nutrition value and health care function of yellow wine. China Brewing 1998 98 : 34 35.
13. Xie GF, Dai J, Zhao GA. Scientifically understanding of the health-protect function of rice wine. China Brewing 2004 13 : 30 31.
14. Guo H, Wang P, You B, Xing Y, Lee JD. Chinese yellow wine inhibits production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Clin Nutr 2007 26 : 348 354. (Pubitemid 46760479) (Pubitemid 46760479) (Pubitemid 46760479)
15. Napoli C, Balestrieri ML, Lerman LO, et al. Beneficial effects of low doses of red wine consumption on per turbed shear stress-induced atherogenesis. Heart Vessels 2008 23 : 124 133.
16. Lefevre J, Michaud SE, Haddad P, et al. Moderate consumption of red wine (Caberner sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: Effect on endothelial progenitor cells and nitric oxide. FASEB J 2007 21 : 3845 3852.
17. Tewari PC, Zhang B, Bluestein BI. Analytical and clinical evaluation of the Bayer ADVIA Centaur homocysteine assay. Clin Chim Acta 2004 342 : 171 178.
18. Chen J, Li D, Schaefer R, Mehta JL. Cross-talk between dyslipidemia and rennin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis 2006 184 : 295 301.
19. Guo H, Shi Y, Liu L, Sun A, Xu F, Chi J. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice. Arch Med Res 2009 40 : 345 351.
20. Cheng XW, Kuzuya M, Sasaki T, et al. Green tea catechins inhibit neointimal hyperplasia in a rat carotid arterial injury model by TIMP-2 overexpression. Cardiovasc Res 2004 62 : 594 602.
21. Chow AK, Cena J, Schulz R. Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature. Br J Pharmacol 2007 152 : 189 205.
22. Foda HD, George S, Rollo E, et al. Regulation of gelatinases in human airway smooth muscle cells: Mechanism of progelatinase A activation. Am J Physiol 1999 277 (1 pt 1 L174 L182.
23. Uzui H, Lee JD, Shimizu H, Tsutani H, Ueda T. The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Atherosclerosis 2000 149 : 51 59.
24. Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler Thromb Vasc Biol 2006 26 : 1120 1125.
25. Corder R, Douthwaite JA, Lees DM, Khan NQ, Viseu Dos Santos AC, Wood EG, Carrier MJ. Endothelin-1 synthesis reduced by red wine. Nature 2001 414 : 863 864.
26. Wallerath T, Poleo D, Li H, Förstermann U. Red wine increases the expression of human endothelial nitric oxide synthase. J Am Coll Cardiol 2003 41 : 471 478.
27. Leikert JF, Rathel TR, Wohlfart P. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 2002 106 : 1614 1617.
28. Linn S, Carroll M, Johnson C, Fulwood R, Kalsbeek W, Briefel R. High-density lipoprotein cholesterol and alcohol consumption in US white and black adults: Data from NHANES II. Am J Public Health 1993 83 : 811 816.
29. Mukamal KJ, Jensen MK, Grønbæk M, Stampfer MJ, Manson JE, Pischon T, Rimm EB. Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation 2005 112 : 1406 1413.
30. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 2005 61 : 549 554.
31. Escolà-Gil JC, Calpe-Berdiel L, Ribas V, Blanco-Vaca F. Moderate beer consumption does not change early or mature atherosclerosis in mice. Nutr J 2004 3 : 1.
32. Tofferi JK, Taylor AJ, Feuerstein IM, O'Malley PG. Alcohol intake is not associated with subclinical coronary atherosclerosis. Am Heart J 2004 148 : 803 809.
33. Roland S, Ruth AO. Dealcoholized red wine decreases atherosclerosis in apolipoprotein E gene-deficient mice independently of inhibition of lipid peroxidation in the artery wall. Am J Clin Nutr 2004 79 : 123 130.
34. Stoclet JC, Chataigneau T, Ndiaye M, Oak MH, El Bedoui J, Chataigneau M, Schini-Kerth VB. Vascular protection by dietary polyphenols. Eur J Pharmacol 2004 500 : 299 313.
35. Walter A, Etienne-Selloum N, Sarr M, Kane MO, Beretz A, Schini-Kerth VB. Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: Preventive effect of red wine polyphenols. J Vasc Res 2008 45 : 386 394.
36. Mizubuchi H, Yajime T, Aoi N, Tomita T, Yoshikai Y. Isomalto- oligosaccharides polarize Th1-like responses in intestinal and systemic immunity in mice. J Nutr 2005 135 : 2857 2861.
37. Anatoly B. Probiotics: Determinants of survival and growth in the gut. Am J Clin Nutr 2001 73 (Suppl 399s 405s.
38. Guo H, Lee JD, Uzui H, et al. Effects of folic acid and magnesium on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Circ J 2006 70 : 141 146.
39. Guo H, Lee JD, Ueda T, Cheng J, Shan J, Wang J. Hyperhomocysteinaemia & folic acid supplementation in patients with high risk of coronary artery disease. Indian J Med Res 2004 119 : 33 37.
40. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998 338 : 1042 1050. (Pubitemid 128753793) (Pubitemid 128753793) (Pubitemid 128753793)
41. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002 288 : 2015 2022.
42. Doronzo G, Russo I, Mattiello L, Trovati M, Anfossi G. Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways. Thromb Haemost 2005 94 : 1285 1293.
43. Ovechkin AV, Tyagi N, Sen U, Lominadze D, Steed MM, Moshal KS, Tyagi SC. 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemiamic mice. Am J Physiol Lung Cell Mol Physiol 2006 291 : L905 L911.